‪Zachary van Rijn‬ - ‪Google Scholar‬

Get my own profile

Cited by

	All	Since 2019
Citations	52	52
h-index	3	3
i10-index	2	2

0

14

7

2019202020212022202320247 5 14 7 14 5

Public access

1 article

0 articles

available

not available

Based on funding mandates

Co-authors

Chanchala KaddiTranslational Disease Modeling (QSP) at SanofiVerified email at sanofi.com
Jeffrey S. BarrettChief Science Officer, Aridhia BioinformaticsVerified email at aridhia.com
John TolsmaRES GroupVerified email at resgroupinc.com
Silvia ParoloThe Microsoft Research - University of Trento Centre for Computational and Systems Biology - COSBIVerified email at cosbi.eu

Zachary van Rijn

Zachary van Rijn

Sanofi

Verified email at zv.io


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Quantitative systems pharmacology modeling of acid sphingomyelinase deficiency and the enzyme replacement therapy olipudase alfa is an innovative tool for linking … CD Kaddi, B Niesner, R Baek, P Jasper, J Pappas, J Tolsma, J Li, ... CPT: Pharmacometrics & Systems Pharmacology 7 (7), 442-452, 2018	27	2018
A quantitative systems pharmacology model of Gaucher disease type 1 provides mechanistic insight into the response to substrate reduction therapy with eliglustat R Abrams, CD Kaddi, M Tao, RJ Leiser, G Simoni, F Reali, J Tolsma, ... CPT: pharmacometrics & systems pharmacology 9 (7), 374-383, 2020	17	2020
Integrated quantitative systems pharmacology (QSP) model of lysosomal diseases provides an innovative computational platform to support research and therapeutic development for … C Kaddi, F Reali, L Marchetti, B Niesner, S Parolo, G Simoni, S Zaph, ... Molecular Genetics and Metabolism 123 (2), S73-S74, 2018	8	2018

The system can't perform the operation now. Try again later.

Articles 1–3